GlycoMimetics, Inc. (NASDAQ:GLYC) Q4 2023 Earnings Call Transcript

Operator: Good morning, and thank you for joining the GlycoMimetics Q4 and Full Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.

Related Keywords

United States ,American ,Tara Bancroft ,Christian Dinneen ,Bruce Johnson ,Brian Hahn ,Harout Semerjian ,Naureen Quibria ,Children Oncology Group Phase ,Company Counsel At Glycomimetics ,Glycomimetics Inc ,Pediatric Early Phase Clinical Trial Network ,Nasdaq ,Dana Farber Cancer Institute ,American Cancer Society ,National Cancer Institute ,Alliance For Clinical Trials In Oncology ,American Society Of Hematology Research Collaborative ,Call Transcript March ,Full Year ,Christian Dinneen Long ,Company Counsel ,Chief Executive Officer ,Chief Financial Officer ,Edwin Rock ,Chief Medical Officer ,Chief Commercial ,Clinical Trials ,Early Phase Clinical Trial ,American Society ,Hematology Research ,Wall Street Lower Ratings ,Capital One ,